title: [Extended indications for percutaneous coronary interventions after successful thrombolysis].
abstract: The study compared the efficiency of percutaneous coronary interventions (PCI) into infarction-related coronary artery (IRCA) in high-risk patients with acute myocardial infarction (AMI), that were fulfilled 12-24 hours since the pain syndrome onset or during recurrent ischemic episodes 3 days after successful thrombolysis. In the first group (68 patients) invasive restoration of blood flow was fulfilled in 3 days (at average 48 hours) after AMI onset due to recurrent ischemia. In the second group (56 patients) IRCA recanalization was fulfilled in 12-24 hours (at average 20 hours) since pain syndrome onset due to clinical signs of unfavorable outcome high risk. IRCA recanalization was successful in 91% and 97% of cases in the first and second groups, respectively. In all cases injection of contrast media Ultravist 370 was diagnostically significant and visualized coronary arteries free of adverse events. In control group (conservative treatment) IRCA occlusion or subtotal stenosis was diagnosed in 18% and 39% of cases, respectively; stenosis >75% and <75% - in 27% and 16%, respectively.
  
  
  CONCLUSIONS
  in high-risk patients with AMI percutaneous coronary interventions into IRCA can be effective 12-24 hours after successful thrombolytic therapy.
authors.forename: M Sh
authors.initials: MSh
authors.lastname: Khubutiia
authors.forename: I V
authors.initials: IV
authors.lastname: Zakharov
authors.forename: G A
authors.initials: GA
authors.lastname: Gazarian
authors.forename: D A
authors.initials: DA
authors.lastname: Chepkiĭ
authors.forename: S D
authors.initials: SD
authors.lastname: Klimovskiĭ
mesh_terms: D000328:Adult; D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D004452:Echocardiography; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000601:surgery*; D009204:Myocardial Revascularization; D012008:Recurrence
chemical_list: D005343:Fibrinolytic Agents